Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-30 @ 7:53 PM
Study NCT ID:
NCT05219669
Status:
COMPLETED
Last Update Posted:
2024-08-05
First Post:
2022-01-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing Regimens
Sponsor:
Opiant Pharmaceuticals Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
OPNT003-PK-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None